iShares High Yield Corporate Bond BuyWrite Strategy ETF (BATS:HYGW – Get Free Report)’s share price dropped 1% on Wednesday . The company traded as low as $29.92 and last traded at $30.13. Approximately 165,311 shares traded hands during trading, an increase of 212% from the average daily volume of 52,973 shares. The stock had previously closed at $30.42.
iShares High Yield Corporate Bond BuyWrite Strategy ETF Stock Down 1.0%
The firm has a market cap of $225.98 million, a price-to-earnings ratio of 10.56 and a beta of 0.24. The stock has a fifty day moving average price of $30.21 and a 200-day moving average price of $30.42.
Hedge Funds Weigh In On iShares High Yield Corporate Bond BuyWrite Strategy ETF
A hedge fund recently raised its stake in iShares High Yield Corporate Bond BuyWrite Strategy ETF stock. RiverFront Investment Group LLC lifted its stake in iShares High Yield Corporate Bond BuyWrite Strategy ETF (BATS:HYGW – Free Report) by 148.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 34,874 shares of the company’s stock after acquiring an additional 20,843 shares during the quarter. RiverFront Investment Group LLC owned approximately 0.46% of iShares High Yield Corporate Bond BuyWrite Strategy ETF worth $1,067,000 as of its most recent filing with the Securities and Exchange Commission.
iShares High Yield Corporate Bond BuyWrite Strategy ETF Company Profile
The iShares High Yield Corporate Bond Buywrite Strategy ETF (HYGW) is an exchange-traded fund that is based on the Cboe HYG BuyWrite index. The fund uses a fund-of-fund approach to passively track an index that measures the performance of holding shares of the iShares High Yield Corporate Bond ETF and writing one-month call options against the shares.
Featured Stories
- Five stocks we like better than iShares High Yield Corporate Bond BuyWrite Strategy ETF
- What Are Treasury Bonds?
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Most active stocks: Dollar volume vs share volume
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- With Risk Tolerance, One Size Does Not Fit All
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for iShares High Yield Corporate Bond BuyWrite Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares High Yield Corporate Bond BuyWrite Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.